Follow
Katherine Lawler
Katherine Lawler
Verified email at cam.ac.uk - Homepage
Title
Cited by
Cited by
Year
ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 Presentation
J Monypenny, H Milewicz, F Flores-Borja, G Weitsman, A Cheung, ...
Cell Reports 24 (3), 630-641, 2018
1232018
RORγt+ Innate Lymphoid Cells Promote Lymph Node Metastasis of Breast Cancers
S Irshad, F Flores-Borja, K Lawler, J Monypenny, R Evans, V Male, ...
Cancer Research 77 (5), 1083-1096, 2017
1202017
MicroRNA‐196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance
YE Suh, N Raulf, J Gäken, K Lawler, TG Urbano, J Bullenkamp, S Gobeil, ...
International Journal of Cancer 137 (5), 1021-1034, 2015
1062015
A transcriptomic signature of the hypothalamic response to fasting and BDNF deficiency in Prader-Willi syndrome
E Bochukova, K Lawler, S Croizier, JM Keogh, N Patel, G Strohbehn, ...
Cell Reports 22 (13), 3401-3408, 2018
892018
How Förster resonance energy transfer imaging improves the understanding of protein interaction networks in cancer biology
GO Fruhwirth, LP Fernandes, G Weitsman, G Patel, M Kelleher, K Lawler, ...
Chemphyschem 12 (3), 442-461, 2011
612011
Steroid receptor coactivator-1 modulates the function of Pomc neurons and energy homeostasis
Y Yang, AA van der Klaauw, L Zhu, TM Cacciottolo, Y He, LKJ Stadler, ...
Nature Communications 10 (1), 1718, 2019
572019
Integrin-Mediated Macrophage Adhesion Promotes Lymphovascular Dissemination in Breast Cancer
R Evans, F Flores-Borja, S Nassiri, E Miranda, K Lawler, A Grigoriadis, ...
Cell Reports 27 (7), 1967-1978. e4, 2019
422019
The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility
T Kiuchi, E Ortiz-Zapater, J Monypenny, DR Matthews, LK Nguyen, ...
Science signaling 7 (339), ra78-ra78, 2014
412014
HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status
G Weitsman, PR Barber, LK Nguyen, K Lawler, G Patel, N Woodman, ...
Oncotarget 7 (32), 51012-51026, 2016
382016
The use of molecular imaging combined with genomic techniques to understand the heterogeneity in cancer metastasis
R Chowdhury, B Ganeshan, S Irshad, K Lawler, M Eisenblätter, ...
The British journal of radiology 87 (1037), 20140065, 2014
352014
Contributions of transcription and mRNA decay to gene expression dynamics of fission yeast in response to oxidative stress
S Marguerat, K Lawler, A Brazma, J Bähler
RNA biology 11 (6), 702-714, 2014
322014
DART: Denoising Algorithm based on Relevance network Topology improves molecular pathway activity inference
Y Jiao, K Lawler, GS Patel, A Purushotham, AF Jones, A Grigoriadis, ...
BMC bioinformatics 12 (1), 403, 2011
322011
Leptin-mediated changes in the human metabolome
K Lawler, I Huang-Doran, T Sonoyama, TH Collet, JM Keogh, E Henning, ...
JCEM, https://doi.org/10.1210/clinem/dgaa251, 2020
262020
Genomic clustering and co-regulation of transcriptional networks in the pathogenic fungus Fusarium graminearum
K Lawler, K Hammond-Kosack, A Brazma, RMR Coulson
BMC systems biology 7 (1), 52, 2013
242013
Association between hypoxic volume and underlying hypoxia-induced gene expression in oropharyngeal squamous cell carcinoma
Y Suh, K Lawler, R Henley-Smith, L Pike, R Leek, S Barrington, EW Odell, ...
British Journal of Cancer 116 (8), 1057-1064, 2017
222017
Memory effects in biochemical networks as the natural counterpart of extrinsic noise
KJ Rubin, K Lawler, P Sollich, T Ng
Journal of theoretical biology 357, 245-267, 2014
222014
The challenges of integrating molecular imaging into the optimization of cancer therapy
GS Patel, T Kiuchi, K Lawler, E Ofo, GO Fruhwirth, M Kelleher, E Shamil, ...
Integrative Biology 3 (6), 603-631, 2011
192011
Human loss-of-function variants in the serotonin 2C receptor associated with obesity and maladaptive behavior
Y He, B Brouwers, H Liu, H Liu, K Lawler, E Mendes de Oliveira, DK Lee, ...
Nature Medicine 28 (12), 2537-2546, 2022
142022
Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans
JM Vicencio, R Evans, R Green, Z An, J Deng, C Treacy, R Mustapha, ...
Cell Death & Disease 13 (3), 1-14, 2022
142022
Imaging tumour heterogeneity of the consequences of a PKCα–substrate interaction in breast cancer patients
G Weitsman, K Lawler, MT Kelleher, JE Barrett, PR Barber, E Shamil, ...
Biochemical Society Transactions 42 (6), 1498-1505, 2014
142014
The system can't perform the operation now. Try again later.
Articles 1–20